1. Home
  2. SGMT vs TTSH Comparison

SGMT vs TTSH Comparison

Compare SGMT & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • TTSH
  • Stock Information
  • Founded
  • SGMT 2006
  • TTSH 1985
  • Country
  • SGMT United States
  • TTSH United States
  • Employees
  • SGMT N/A
  • TTSH N/A
  • Industry
  • SGMT
  • TTSH Blank Checks
  • Sector
  • SGMT
  • TTSH Finance
  • Exchange
  • SGMT Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • SGMT 238.7M
  • TTSH 264.5M
  • IPO Year
  • SGMT 2023
  • TTSH N/A
  • Fundamental
  • Price
  • SGMT $7.31
  • TTSH $6.28
  • Analyst Decision
  • SGMT Strong Buy
  • TTSH
  • Analyst Count
  • SGMT 7
  • TTSH 0
  • Target Price
  • SGMT $26.57
  • TTSH N/A
  • AVG Volume (30 Days)
  • SGMT 480.3K
  • TTSH 104.3K
  • Earning Date
  • SGMT 11-12-2025
  • TTSH 11-06-2025
  • Dividend Yield
  • SGMT N/A
  • TTSH N/A
  • EPS Growth
  • SGMT N/A
  • TTSH N/A
  • EPS
  • SGMT N/A
  • TTSH N/A
  • Revenue
  • SGMT N/A
  • TTSH $340,228,000.00
  • Revenue This Year
  • SGMT N/A
  • TTSH N/A
  • Revenue Next Year
  • SGMT N/A
  • TTSH N/A
  • P/E Ratio
  • SGMT N/A
  • TTSH N/A
  • Revenue Growth
  • SGMT N/A
  • TTSH N/A
  • 52 Week Low
  • SGMT $1.73
  • TTSH $4.62
  • 52 Week High
  • SGMT $11.41
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 52.06
  • TTSH 52.73
  • Support Level
  • SGMT $7.11
  • TTSH $5.78
  • Resistance Level
  • SGMT $7.66
  • TTSH $6.47
  • Average True Range (ATR)
  • SGMT 0.40
  • TTSH 0.31
  • MACD
  • SGMT 0.11
  • TTSH -0.02
  • Stochastic Oscillator
  • SGMT 76.45
  • TTSH 40.14

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: